NOVOTHYRAL

This brand name is authorized in Austria, Estonia, Poland, Romania

Active ingredients

The drug NOVOTHYRAL contains a combination of these active pharmaceutical ingredients (APIs):

1 Levothyroxine UNII 9J765S329G - LEVOTHYROXINE SODIUM

Levothyroxine sodium is used for the treatment of hypothyroidism. The chief action of levothyroxine is to increase the rate of cell metabolism. Read about Levothyroxine

2 Liothyronine UNII GCA9VV7D2N - LIOTHYRONINE SODIUM

Liothyronine sodium is a naturally occurring thyroid hormone. The biological action of liothyronine sodium is quantitatively similar to that of levothyroxine sodium. Read about Liothyronine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H03AA03	Combinations of levothyroxine and liothyronine	H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03A Thyroid preparations → H03AA Thyroid hormones
Discover more medicines within H03AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1617173
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100048529, 100048535
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66150001